A
Annovis Bio D
D
ANVS
1.98000
USD
-0.06
(-2.94%)
مغلق
حجم التداول
3,539
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
38,582,737
الأخبار المقالات
العنوان: Annovis Bio
القطاع: Healthcare
الصناعة: Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.